Adrenocorticotropin, glucocorticoid, and androgen secretion in patients with new onset synovitis/rheumatoid arthritis: relations with indices of inflammation.

To determine whether alterations in adrenocortical function occur early in the development of inflammatory joint disease, we examined patients with new onset synovitis (<1 yr) prior to treatment with corticosteroids or other disease-modifying antirheumatic drugs. Thirty-two patients with new onset synovitis, including 15 fitting criteria for rheumatoid arthritis (RA), taking no medications, were referred for study by local rheumatologists; 32 age- and sex-matched healthy individuals were recruited as controls. Patients and controls had blood drawn under identical conditions between 0900 and 1100 h. Plasma ACTH, cortisol, dehydroepiandrosterone (DHEA), DHEA sulfate, free and total testosterone, erythrocyte sedimentation rate, C-reactive protein, and rheumatoid factor were measured. Compared with controls, patients had higher inflammatory indices (erythrocyte sedimentation rate, C-reactive protein) and lower basal morning levels of free testosterone (lower in males age > or =45 yr), but similar levels of ACTH, cortisol, DHEA, DHEA sulfate, and total testosterone. In addition, the positive correlations between ACTH-cortisol, ACTH-DHEA, and cortisol-DHEA, observed in the normal controls, were weakened or abolished in the patients (both total and RA subset). No positive relations between inflammatory indices and ACTH or cortisol were noted, yet an inverse correlation between these indices and DHEA and testosterone was observed. Moreover, a steeper age-associated decline in DHEA was observed in our cross-sectional sample of patients with new onset synovitis. We conclude that patients with synovitis (including those fitting criteria for RA) have adrenocortical hormone alterations within a year of disease onset. Paradoxically, these patients have no positive relation between indices of inflammation and ACTH or cortisol, but rather serum androgen levels are inversely correlated with these indices. In addition, the relations between ACTH, the classic stimulus of cortisol and adrenal androgens, and these hormones are weakened or abolished, whereas the negative relation between age and zona reticularis function is steeper than that of controls.

[1]  S. Bale,et al.  Association of HLA alleles and clinical features in patients with synovitis of recent onset. , 1999, Arthritis and rheumatism.

[2]  J. Bijlsma,et al.  Estrogens and Rheumatoid Arthritis , 1992, American journal of reproductive immunology.

[3]  F. Arnett Revised criteria for the classification of rheumatoid arthritis. , 1990, Orthopedic nursing.

[4]  H. Zeidler,et al.  Undifferentiated arthritis and reactive arthritis. , 1998, Current opinion in rheumatology.

[5]  R. Pope,et al.  Effect of pregnancy on immune complexes and rheumatoid factors in patients with rheumatoid arthritis. , 1983, The American journal of medicine.

[6]  M. Liang,et al.  The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. , 1988, Arthritis and rheumatism.

[7]  R. Wilder Adrenal and gonadal steroid hormone deficiency in the pathogenesis of rheumatoid arthritis. , 1996, The Journal of rheumatology. Supplement.

[8]  G. Chrousos,et al.  Inflammatory mediator-induced hypothalamic-pituitary-adrenal axis activation is defective in streptococcal cell wall arthritis-susceptible Lewis rats. , 1989, Proceedings of the National Academy of Sciences of the United States of America.

[9]  A. Reunanen,et al.  Serum androgen-anabolic hormones and the risk of rheumatoid arthritis , 1998, Annals of the rheumatic diseases.

[10]  G. Kingsley,et al.  Defective hypothalamic response to immune and inflammatory stimuli in patients with rheumatoid arthritis. , 1992, Arthritis and rheumatism.

[11]  E. Keller,et al.  Inhibition of NFkappaB activity through maintenance of IkappaBalpha levels contributes to dihydrotestosterone-mediated repression of the interleukin-6 promoter. , 1996, The Journal of biological chemistry.

[12]  A. Masi,et al.  Estrogens, the immune response and autoimmunity. , 1995, Clinical and experimental rheumatology.

[13]  W. Regelson,et al.  Dehydroepiandrosterone (DHEA)--the multifunctional steroid. II. Effects on the CNS, cell proliferation, metabolic and vascular, clinical and other effects. Mechanism of action? , 1994, Annals of the New York Academy of Sciences.

[14]  W. Regelson,et al.  Dehydroepiandrosterone (DHEA)–the Multifunctional Steroid , 1994 .

[15]  D. Farber,et al.  Dissociation of adrenal androgen and cortisol levels in acute stress. , 1985, Hormone and metabolic research = Hormon- und Stoffwechselforschung = Hormones et metabolisme.

[16]  M. Cutolo,et al.  Hypothalamic-pituitary-adrenocortical axis function in premenopausal women with rheumatoid arthritis not treated with glucocorticoids. , 1999, The Journal of rheumatology.

[17]  Xu,et al.  Indomethacin Attenuates Oxytocin and Hypothalamic‐Pituitary‐Adrenal Axis Responses to Systemic Interleukin‐1β , 1998, Journal of neuroendocrinology.

[18]  G. Panayi Hormonal control of rheumatoid inflammation. , 1995, British medical bulletin.

[19]  G. Chrousos,et al.  Clinical review 104: Adrenocorticotropin (ACTH)- and non-ACTH-mediated regulation of the adrenal cortex: neural and immune inputs. , 1999, The Journal of clinical endocrinology and metabolism.

[20]  W. Scherbaum,et al.  Regulation of adrenocortical function by cytokines--relevance for immune-endocrine interaction. , 1998, Hormone and metabolic research = Hormon- und Stoffwechselforschung = Hormones et metabolisme.

[21]  A. Masi,et al.  Neuroendocrine, immunologic, and microvascular systems interactions in rheumatoid arthritis: physiopathogenetic and therapeutic perspectives. , 1999, Seminars in arthritis and rheumatism.

[22]  R L Wilder,et al.  Neuroendocrine-immune system interactions and autoimmunity. , 1995, Annual review of immunology.

[23]  W. Graninger,et al.  Anterior pituitary function in patients with newly diagnosed rheumatoid arthritis. , 1996, British journal of rheumatology.

[24]  G. Chrousos,et al.  Circadian relationships between interleukin (IL)-6 and hypothalamic-pituitary-adrenal axis hormones: failure of IL-6 to cause sustained hypercortisolism in patients with early untreated rheumatoid arthritis. , 1997, The Journal of clinical endocrinology and metabolism.

[25]  A. Masi,et al.  Sex hormones and rheumatoid arthritis: cause or effect relationships in a complex pathophysiology? , 1995, Clinical and experimental rheumatology.

[26]  B. Skogseid,et al.  Intact adrenocorticotropic hormone secretion but impaired cortisol response in patients with active rheumatoid arthritis. Effect of glucocorticoids. , 1996, The Journal of rheumatology.

[27]  N. Olsen,et al.  Castration alters peripheral immune function in normal male mice. , 1995, Immunology.

[28]  R. Loria,et al.  Dehydroepiandrosterone (DHEA)‐the “Mother Steroid” , 1994 .

[29]  A. Silman,et al.  Does rheumatoid arthritis remit during pregnancy and relapse postpartum? Results from a nationwide study in the United Kingdom performed prospectively from late pregnancy. , 1999, Arthritis and rheumatism.

[30]  M. Cutolo,et al.  Immunomodulatory Mechanisms Mediated by Sex Hormones in Rheumatoid Arthritis a , 1996, Annals of the New York Academy of Sciences.

[31]  E. Morand,et al.  Glucocorticoids in rheumatoid arthritis--mediators and mechanisms. , 1993, British Journal of Rheumatology.

[32]  D. Papanicolaou,et al.  The Pathophysiologic Roles of Interleukin-6 in Human Disease , 1998, Annals of Internal Medicine.

[33]  R. Daynes,et al.  Altered regulation of IL-6 production with normal aging. Possible linkage to the age-associated decline in dehydroepiandrosterone and its sulfated derivative. , 1993, Journal of immunology.

[34]  I. Elenkov,et al.  Hormonal Regulation of Tumor Necrosis Factor‐α, Interleukin‐12 and Interleukin‐10 Production by Activated Macrophages: A Disease‐modifying Mechanism in Rheumatoid Arthritis and Systemic Lupus Erythematosus? , 1999, Annals of the New York Academy of Sciences.

[35]  G. Chrousos,et al.  Recombinant interleukin-6 activates the hypothalamic-pituitary-adrenal axis in humans. , 1993, The Journal of clinical endocrinology and metabolism.

[36]  M. V. van Leeuwen,et al.  Clinical significance of interleukin-6 measurement in early rheumatoid arthritis: relation with laboratory and clinical variables and radiological progression in a three year prospective study. , 1995, Annals of the rheumatic diseases.

[37]  J. Takahara,et al.  Effect of continuous intravenous injection of interleukin-6 and pretreatment with cyclooxygenase inhibitor on brain c-fos expression in the rat. , 1997, Neuroendocrinology.

[38]  H. Broxmeyer,et al.  Regulation of interleukin-6, osteoclastogenesis, and bone mass by androgens. The role of the androgen receptor. , 1995, The Journal of clinical investigation.

[39]  Serum dehydroepiandrosterone (DHEA) and DHEA sulfate are negatively correlated with serum interleukin-6 (IL-6), and DHEA inhibits IL-6 secretion from mononuclear cells in man in vitro: possible link between endocrinosenescence and immunosenescence. , 1998, The Journal of clinical endocrinology and metabolism.

[40]  L. Lisá [Effects of glucocorticoids]. , 1977, Ceskoslovenska pediatrie.

[41]  M. Cutolo The role of the hypothalamus-pituitary-adrenocortical and -gonadal axis in rheumatoid arthritis. , 1998, Clinical and experimental rheumatology.

[42]  A. Masi,et al.  Hormonal and pregnancy relationships to rheumatoid arthritis: convergent effects with immunologic and microvascular systems. , 1995, Seminars in arthritis and rheumatism.

[43]  L. Bonomo,et al.  Antineutrophil cytoplasmic antibodies in synovial fluid and in serum of patients with rheumatoid arthritis and other types of synovitis. , 1996, Journal of Rheumatology.

[44]  H. Zeidler,et al.  Undifferentiated arthritis in an early synovitis out-patient clinic. , 1995, Clinical and experimental rheumatology.